The potential of ATP-sensitive potassium channel openers (KCOs) for the treatment of male erectile dysfunction has recently been suggested based on positive clinical outcomes following intra-cavernosal administration of pinacidil. Agents that increase the levels of cGMP via elevation of nitric oxide (NO) nitroglycerin, for example, are also effective in improving erectile function preclinically and clinically. The aim of the present study was to determine the effects and mechanism of the action of nicorandil on rabbit corpus cavernosum. The in vitro regulation of smooth muscle tone was assessed in isolated cavernosal tissues pre-contracted with phenylephrine. Nicorandil, but not its major metabolite, relaxed phenylephrine-precontracted cavernosum smooth muscle with an EC 50 of 15 m m mM. The effects of nicorandil were only partially reversed by the K ATP channel blocker glyburide (10 m m mM) or by a soluble guanylate cyclase (sGC) inhibitor 1H-[1,2,4] oxadiazole [4,3-a] quinoxalin-1-one (ODQ, 3 m m mM). However, a combination of ODQ and glyburide completely blocked the relaxant effects of nicorandil. The results of the present study indicate that nicorandil can relax rabbit cavernosal tissue in vitro via a mechanism that involves activation of K ATP channels and stimulation of soluble guanylate cyclase.
Introduction
Corpus cavernosal smooth muscle tone is controlled by a number of discrete signaling pathways coordinated at the level of the peripheral and central nervous system. This smooth muscle tone ultimately regulates penile¯accidity and erection. 1 Contraction is primarily mediated by alphaadrenoceptor stimulation 1,2 while relaxation is mediated by the interaction of several types of neurotransmission, including nonadrenergic ± noncholinergic (NANC) neural input and the release of nitric oxide, 1, 3 Nitric oxide, released from NANC nerve terminals and from cholinergically-activated endothelial cells, diffuses into adjacent smooth muscle cells where it activates soluble guanylate cyclase. This increases the intracellular levels of cyclic guanosine monophosphate (cGMP) that leads to the relaxation of cavernosal smooth muscle. The increased blood¯ow and engorgement of the trabecular spaces results in veno-occlusion and penile erection. Nitrovasodilators (organic nitrates and NO donors) have shown limited ef®cacy in clinical trials for male erectile dysfunction. 4 However, since these agents relax the peripheral vasculature via a similar mechanism and are prone to systemic side-effects, 5 they must be administered locally by intracavernosal injection or topically.
ATP-sensitive potassium channels (K ATP ) are an important family of potassium channels that couple cellular energy metabolism to membrane electrical activity. 6, 7 At physiologic ATP levels, K ATP channels remain mostly in their closed state while at low ATP levels, the channels open. Potassium channel openers (KCOs) such as L-cromakalim, diazoxide, pinacidil and its analogue P1075 activate K ATP channels producing hyperpolarization of vascular and non-vascular smooth muscle membranes which reduce Ca 2 in¯ux through voltage-activated L-type Ca 2 channels, thus resulting in smooth muscle relaxation. 6 Recently, the prototypic potassium channel openers such as L-cromakalim and pinacidil, when administered as intracavernosal injections, have been found effective in the initiation and maintenance of penile erection in experimental animal models 8 ± 10 and in clinical study in humans. 11 Nicorandil (N-(2-hydroxyethyl)nicotinamide nitrate ester) is an orally ef®cacious anti-anginal drug. 12 While this agent has been shown to relax human corpus cavernosum, 13 the mechanism under-lying this effect remains to be fully elucidated. The present study was designed to investigate the mechanism of action of nicorandil in rabbit corpus cavernosum. Speci®cally, the role of the KCO and nitrate activities associated with this compound was investigated. Additionally, the possibility that the relaxant effects of nicorandil are mediated via its major metabolite was also assessed.
Materials and methods

Drugs
Nicorandil (N-(2-hydroxyethyl) nicotinamide nitrate ester) and its metabolite N-(2-hydroxyethyl) nicotinamide (Figure 1 ), K ATP channels openers L-cromakalim, P1075, and K ATP channel blocker glyburide were synthesized at Abbott Laboratories (Abbott Park, IL). Guanylate cyclase inhibitor ODQ (1H- [1, 2, 4] oxadiazolo [4,3-a] quinoxalin-1-one), diazoxide, sodium nitroprusside, and phenylephrine were purchased from Sigma Chemical Co. (St Louis, MO). Nicorandil was dissolved in dimethyl sulfoxide (DMSO) to make a 100 mM stock solution. All drugs, unless indicated otherwise, were further diluted with ethanol before adding into the buffer solutions in tissue bath chamber so that the ®nal total solvent (DMSO plus ethanol) concentrations in the assays was less than 0.5% (vav) which itself did not alter the smooth muscle tone. Stock solutions of phenylephrine prepared in saline included 0.1% ascorbic acid as an antioxidant.
Tissue preparation
The in vitro regulation of smooth muscle tone was assessed using isolated rabbit cavernosum smooth muscle strips mounted in organ bath chamber and pre-contracted with phenylephrine. Corpus cavernosum tissues were prepared from adult male New Zealand white rabbits (Covance Research Production, Kalamazoo, MI), weighing 3.0 ± 3.5 kg, after euthanasia by intravenous pentobarbital sodium injection. The two corpus cavernosum strips were carefully dissected under a illuminated magni®er (a slit was made in the proximal end of the tunica and extended distally and the corpus cavernosum was dissected free of the tunica albuginea and surrounding connective tissues). Each tissue strip was longitudinally cut into three strip preparations measuring approximately 26267 mm (unstretched length, mean weight $ 30 mg).
Measurement of isometric tension
The strips were transferred and mounted to organ baths (10 ml) containing Kreb ± Henseleit buffer solution (pH 7.4) maintained at 37 C by a thermoregulated water circuit. The buffer solution contained D-glucose 2.0 gal, MgSO 4 0.141 gal, KH 2 PO 4 0.16 gal, KCl 0.35 gal, NaCl 6.9 gal (Sigma Chemical Co) plus CaCl 2 .2H 2 O 0.373 gal and NaHCO 3 2.1 gal. The buffer was continuously aerated with a mixture of 95% O 2 a5% CO 2 . The tissue strips were loaded with a resting tension of 2 g and equilibrated for 90 min. During equilibration, the bath solution was replaced every 10 ± 15 min. Changes in isometric tension of muscle tissues were measured using a force-displacement transducer (Grass FT03 model, Grass Instruments Co., Quincy, MA) and recorded on a Grass 7D model polygraph. Repeated adjustment of tension was performed if necessary. No changes in tension were made after the experiment was started.
Drug treatment
The relaxation effects of nicorandil, nicorandil metabolite, L-cromakalim, P1075, diazoxide, and sodium nitroprusside were assessed in rabbit corpus cavernosum preparations precontracted with phenylephrine (1.5 mM). At stable tension, compounds to be tested were added cumulatively at half log unit increments, and a new concentration was not added until the response to the previous one had attained a steady state tension.
In another set of experiments, tissue preparations were contracted with phenylephrine 1.5 mM and subsequently treated with 3 ± 10 mM ODQ (a guanylate cyclase inhibitor), 10 mM glyburide (for competitive blockade of ATP-dependent K channel), or combination of ODQ (3 mM) and glyburide (10 mM) for 15 min. The inhibitors were added after the phenylephrine-induced contraction reached K ATP and guanylate cyclase activation by nicorandil GC Hsieh et al steady-state. A cumulative concentration ± response curve was then constructed for the relaxant agents above described.
Data analysis
Sigmoid curves were ®tted to concentrationresponse data by nonlinear regression analysis (GraphPAD, San Diego, CA) to obtain EC 50 values as appropriate. Data are expressed as the mean AE s.e.m.
Results
Effects of nicorandil and its metabolite on phenylephrine contracted corpus cavernosal strips
Phenylephrine contracted isolated rabbit corpus cavernosal tissue strips in a concentration-dependent manner with an EC 50 of 1.5 mM. To investigate the relaxant effects of nicorandil, corpus cavernosum strips were precontracted with phenylephrine (1.5 mM) and then treated with increasing concentrations of compound (10 78 ± 10 74 M). Nicorandil elicited a concentration-dependent relaxation of smooth muscle strips ( Figure 2) ; the potency (EC 50 ) determined from cumulative concentration ± response curve was 15 mM. In contrast, the major metabolite of nicorandil (N-(2-hydroxyethyl) nicotinamide) did not relax phenylephrine precontracted cavernosum tissue at concentrations up to 100 mM ( Figure 2 ).
Effects of K ATP channel openers P1075, L-cromakalim, and diazoxide on phenylephrine contracted corpus cavernosal strips
In order to determine the effect of other KCOs lacking nitrate activity on rabbit corpus cavernosal smooth muscle tone, three reference openers, P1075, L-cromakalim, and diazoxide, were evaluated. All three KCOs relaxed the tissue preparation in a concentration-dependent manner. The EC 50 values for P1075, L-cromakalim and diazoxide were 0.064, 0.75, and 85 mM, respectively ( Figure 3 ). The rank order of potency of these compounds in this tissue is similar to that reported previously for other smooth muscle tissues. 14 L-cromakalim-induced relaxation was completely inhibited by the pretreatment with the selective K ATP channel blocker, glyburide ( Figure 4 ).
Effects of guanylate cyclase activator sodium nitroprusside on phenylephrine contracted corpus cavernosal strips
The NO-donor sodium nitroprusside (10 79 ± 10 75 M) produced a concentration-dependent relaxation of the cavernosal tissue strips ( Figure 5 ) with an EC 50 value of 0.37 mM. Pretreatment with the guanylate cyclase inhibitor ODQ (3 and 10 mM) completely blocked the relaxant effects of sodium nitroprusside. In contrast, glyburide (10 mM) had no effect on the relaxant properties of sodium nitroprusside (data not shown). K ATP and guanylate cyclase activation by nicorandil GC Hsieh et al
Effects of glyburide and ODQ on the relaxant response to nicorandil
The studies with KCOs and sodium nitroprusside described above indicated that both K ATP channel activation and guanylate cyclase activation can relax corpus cavernosum. To determine if the relaxant effects of nicorandil are mediated via one or both of these pathways, the effects of glyburide and ODQ alone or in combination on the relaxant effects of nicorandil were investigated. As shown in Figure 6 , the relaxant effects of nicorandil at concentrations`30 mM were completely blocked by glyburide. However, higher concentrations (100 mM) were only partially ( $ 40%) reversed. Similarily, the effects of nicorandil (100 mM) were only partially reversed by ODQ (3 mM). However, in the presence of the combination of glyburide (10 mM) and ODQ (3 mM), the relaxant effects of nicorandil (100 mM) were completely antagonized ( Figure 7 ).
Discussion
In this report we have found that nicorandil effectively relaxes rabbit corpus cavernosum smooth muscle strips pre-contracted with phenylephrine K ATP and guanylate cyclase activation by nicorandil GC Hsieh et al in vitro. This relaxation can be partially blocked by glyburide, suggesting activation of ATP-sensitive K channels; or partially inhibited by ODQ, suggesting soluble guanylate cyclase activation. At concentrations less than 30 mM, nicorandil appears to act through the opening of potassium channels. At higher concentrations, nicorandil appears to act through the NO-activated guanylate cyclase. While both pathways contribute to these effects, they are independent. Further, our studies demonstrate that N-(2-hydroxyethyl) nicotinamide, a main denitrated metabolite of nicorandil, is pharmacologically inactive. Potassium channels regulate membrane potential and modulate smooth muscle tone. 6 Recent studies both in vitro and in vivo have documented the potential physiologicalapathophysiological importance of potassium channels to the modulation of corpus cavernosal smooth muscle tone. 15 ± 18 The K ATP and maxi-K potassium channel subtypes are thought to be the two most physiologically relevant potassium channels expressed in corpus cavernosal smooth muscle. 16, 17 Signi®cant reduction in the sensitivity of precontracted corpus cavernosum smooth muscle tissue strips excised from diabetic patients to relaxation by structurally diverse K ATP channel modulators pinacidil and P1075, when compared to the tissues obtained from non-diabetic patients, suggests that a decrease in expression or an impairment of function in these channels may occur in erectile dysfunction. 18 Transfection of the human maxi-K hSlo cDNA into aged rats in vivo has shown that increased expression of the human maxi-K channel produces the physiologically relevant improvements in penile function. 15 Thus, gene therapy or therapeutic approaches to enhance existing channel activity may be effective treatments for erectile dysfunction.
Agents that decrease cell excitability, due to hyperpolarization of cell membranes following K channel opening, may offer a novel therapeutic approach. 6, 20 Recently, in limited clinical studies in humans, the prototypic potassium channel openers such as pinacidil 11 and PNU-83587 19 when injected intracavernosally, were found to be effective in the initiation and maintenance of penile erection. Unlike intracavernosal injection of PGE 1 there were no complaints of penile pain often associated with injection.
In contrast to relaxation by the potassium channel opener L-cromakalim which was completely blocked by glyburide (Figure 4) , nicorandil-induced relaxation on the smooth muscle tone was only partially inhibited through blocking the glyburidesensitive K ATP channel (Figures 6 and 7) . These data suggest that other pathways besides potassium channel opening activity are responsible for the effects of nicorandil. The present studies also demonstrate that ODQ, a selective inhibitor of soluble guanylate cyclase, signi®cantly inhibits nicorandil-induced relaxation, indicating that soluble guanylate cyclase activation plays an important role on the relaxation effects of nicorandil on phenylephrine precontracted cavernosum smooth muscle. ODQ completely inhibits the effects of NO donor sodium nitroprusside induced relaxation ( Figure 5 ). Guanylate cyclase catalyzes the biosynthesis of cGMP from GTP and exists in two isozyme forms, the soluble form and the membrane-bound form 21 By formation of cGMP as a second messenger, guanylate cyclase plays a critical role in different physiological processes, eg smooth muscle relaxation, platelet aggregation, and neuronal transmission. 1, 2, 21 The most important physiological activator of soluble guanylate cyclase is the endothelium-derived relaxing factor, which is considered to be NO or an NO-related compound. Activation of soluble guanylate cyclase by NO is heme-dependent. 22 ± 24 Therapeutically, vasodilatory agents such as nitroprusside, linsidomine (SIN-1), and nitroglycerin (glyceryl trinitrate) which activate soluble guanylate cyclase after conversion to NO have shown ef®cacy in limited clinical trials in humans for the treatment of erectile dysfunction by intracavernous injection. 4 However, since these agents relax the peripheral vasculature via a similar mechanism and are prone to systemic side-effects, 5 they must be administered locally by intracavernosal injection or topical application.
Recently advances in the physiology of male sexual function have established that corpus cavernosum smooth muscle relaxation is the primary event of penile erection. 1 Clinically, intracavernous injection therapy is the most effective pharmacological treatment for erectile dysfunction. However, the treatment discontinuation rate for the intracavernous injection therapy of alprostadil programs is 50% in many studies because of the method of administration and side effects of penile pain and burning sensations. 4 Our results suggest that nicorandil, a hybrid molecule with K ATP channel opening and nitrate-like properties, appears to hold promise as direct effector of corpus cavernosum smooth muscle relaxation (Figure 8 ). NO released from nicorandil rapidly diffuses into the smooth muscle cells to activate guanylate cyclase, which is responsible for the conversion of GTP to cGMP. The increase of cGMP initiates a series of reactions that ultimately reduce intracellular Ca 2 , leading to the smooth muscle relaxation. The opening of K ATP channels causes cellular membrane hyperpolarization that reduces calcium ion in¯ux through a decreased activity of voltage-dependent calcium channels. This in turn results in corpus cavernosum smooth muscle relaxation. The ®ndings of the mode and mechanism of action of nicorandil suggest that compounds like nicorandil with a dual mechanism may be of clinical importance for male erectile dysfunction because ef®cacy is expected to be increased by employing two independent mechanisms, when drug is administered locally to achieve high enough doses that both K ATP channel opening and guanylate cyclase activation are involved. Nicorandil is a potent vasodilating agent for the treatment of myocardial hypoxia and two postulated mechanisms of action on different parts of the vascular systems have also been reported, 12, 25 the nitrate-like effect of nicorandil inducing the vasodilation of large coronary arteries, and its opening action on K ATP channels dilating the coronary resistance vessels.
In conclusion, nicorandil, but not its non-NO containing metabolite, induced corpus cavernosum smooth muscle relaxation, suggesting the importance of NO in the mechanism. Consistent with this hypothesis, ODQ, an inhibitor of soluble guanylate cyclase, inhibited nicorandil-mediated smooth muscle relaxation. Furthermore, glyburide, an ATP-sensitive K channel blocker, also inhibited the relaxatory effects of nicorandil. Taken together, these data suggest that a dual mechanism involving both NO-mediated activation of soluble guanylate cyclase and the opening of potassium channels is responsible for the effects of nicorandil on corpus cavernosum smooth muscle.
